Speed CPSE

Quantitative dosage of serum or plasma CPSE (Canine Prostate-Specific Esterase)

Presentation

Advantages

Method : Immunochromatography

Analysis: Quantitative assay of serum or plasma and serum CPSE (Canine Prostate-Specific Esterase)

Sample: Serum, heparinized plasma

Reading: 10 minutes

Presentation: 6 tests

Storage: 18 months between + 2°C and + 8°C

Performances: The correlation coefficient R² is 0.97

Speed CPSE^TM is used to measure the level of CPSE (Canine Prostate-Specific Esterase) in dogs.

Simple and quick to implement, Speed CPSE^TM allows the practitioner to perform a Benign Prostatic Hyperplasia screening in clinic based on quantitative result.

Why use Speed CPSE^TM?
Benign Prostatic Hyperplasia (BPH) is one of the most common prostate diseases in dogs⁽¹⁾; it is characterised by proliferation (hyperplasia) and increased size (hypertrophy) of prostatic cells. Such structural changes result in elevated blood levels of Canine Prostate-Specific Esterase (CPSE), an enzyme secreted by the prostate.

Why use Speed CPSE^TM?

Benign Prostatic Hyperplasia (BPH) is one of the most common prostate diseases in dogs⁽¹⁾; it is characterised by proliferation (hyperplasia) and increased size (hypertrophy) of prostatic cells.

Such structural changes result in elevated blood levels of Canine Prostate-Specific Esterase (CPSE), an enzyme secreted by the prostate.

When to use Speed CPSE^TM?
Benign Prostatic Hyperplasia (BPH) is a disease that can occur spontaneously in male dogs from 3 years and the risk increases with age. It affects about 80% of males over 5 years of age, which makes it the most common prostate disease in dogs⁽¹⁾. CPSE levels are high in 97% of BPH cases. ⁽²⁾ Speed CPSE^TMnow enables regular screening in dogs even in the absence of symptoms to prevent and anticipate the risk of BPH.

When to use Speed CPSE^TM?

Benign Prostatic Hyperplasia (BPH) is a disease that can occur spontaneously in male dogs from 3 years and the risk increases with age. It affects about 80% of males over 5 years of age, which makes it the most common prostate disease in dogs⁽¹⁾. CPSE levels are high in 97% of BPH cases. ⁽²⁾

Speed CPSE^TMnow enables regular screening in dogs even in the absence of symptoms to prevent and anticipate the risk of BPH.

Protocol for the use of Speed CPSE^TM

See study

References
(1) Ettinger SJ, Feldman EC. Textbook of Veterinary Internal Medicine. 7th Edition, 2010. Saunders Elsevier, St Louis, Missouri. ISBN: 978-9996962837 (v.2)

(2) Lowseth LA, Gerlach RF, Gillett NA, Muggenburg BA. Age-related changes in the prostate and testes of the beagle dog. Vet Pathol. 1990 Sep;27(5):347-53.